Immunology of the healthy liver: old questions and new insights.
about
Natural Killer Cells and Liver FibrosisImpact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transductionGenetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteinsHepatitis C Virus-Specific T-Cell Gamma Interferon and Proliferative Responses Are More Common in Perihepatic Lymph Nodes than in Peripheral Blood or LiverThe transcriptomic response of rat hepatic stellate cells to endotoxin: implications for hepatic inflammation and immune regulationImmunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration.Isolation of murine hepatic lymphocytes using mechanical dissection for phenotypic and functional analysis of NK1.1+ cells.Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantationHepatic gene transfer as a means of tolerance induction to transgene productsActivation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatmentHepatoimmunology: a perspective.Role of IRAK-M in alcohol induced liver injury.Elevated interferon gamma signaling contributes to impaired regeneration in the aged liver.Expression and distribution of immunoglobulin G in the normal liver, hepatocarcinoma and postpartial hepatectomy liver.Mechanisms of drug-induced liver injury.Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.Designing a multicellular organotypic 3D liver model with a detachable, nanoscale polymeric Space of Disse.An Update on Drug-induced Liver Injury.Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease.Immunomodulatory Role of Kupffer Cell in Liver Allografts.Chronic hepatitis B surface antigen seroclearance-related immune factors.The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy (ALPPS) Maintains the Immunological Components of a Healthy OrganHepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1.The combination therapy of α-galactosylceramide and 5-fluorouracil showed antitumor effect synergistically against liver tumor in mice.Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma.Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9.Optimization of mesenchymal stem cells (MSCs) delivery dose and route in mice with acute liver injury by bioluminescence imaging.Role of NKT Cells in the Pathogenesis of NAFLD.Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver.Drug-induced liver injury: is it somehow foreseeable?Human interleukin-15 improves engraftment of human T cells in NOD-SCID mice.Hepatic B cells are readily activated by Toll-like receptor-4 ligation and secrete less interleukin-10 than lymphoid tissue B cells.Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species.Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.Reduction of CD45RA isoform expression and decrease in CD4 and CD8 receptor density in lymphocytes of patients with primary biliary cirrhosis.Ventriculoportal Shunt, a New Transomphalic Extraperitoneal Surgical Technique in Treatment of Hydrocephalus.Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
P2860
Q26767448-7B6B0940-4354-44A6-930F-E68C7FB671AEQ27307010-F3D8ADE1-67F5-454B-8153-38657915E389Q27470000-6295581D-86FF-4E87-BFAE-FB7BF8D0A45CQ27487339-599C51FC-B318-44D8-B7A3-60832F2FB5EFQ28536567-751BC94C-3510-436B-BE11-976CB06196F1Q30252731-66A4054E-5CDA-4ECA-9282-952FFCE04457Q33204301-5D8A5D3A-00CB-47C5-8453-10CE09F47918Q33398529-7D541F94-D719-4A0E-B331-FFFEC04BDA63Q33775537-67003668-97A8-41FB-B628-06ECF63374EBQ33893099-D2E5E493-3B89-4F73-A705-F8C0F12EB432Q34347862-3A0D00AA-27ED-4F3E-9496-B3568F59FBBDQ34546424-3E0257C7-CE8A-4B52-B2B5-16F6E5799B1CQ34600023-9FA10E7F-0905-458C-B3CF-A1163C66312BQ35166230-8DCBD8A9-1825-4079-8299-18A33093BC96Q35283776-F7B911FA-E501-48E4-AFE4-F88C8600905FQ36439183-4DC10170-D111-4BE6-8F89-57FD2B6CBAB8Q36930091-37B6ABA8-82DF-45C3-9092-225358068A73Q37222831-F4A1EE69-9928-462D-BE48-234EAC8E321BQ37613520-D24CF237-29F9-42F9-A52C-462FA1FB2813Q38247990-C09431A7-3ACB-4D44-96DC-E662AEFF0E27Q38807405-A7445F8F-1817-42D3-BDF5-320E11285CF1Q38809744-09FD478E-91F4-44A2-B5FA-B12486C82992Q38828363-E076085E-4FF0-4BF8-835D-3211DB9CE730Q38877460-85580A31-453F-45C7-B162-DAE857D99C35Q39192254-E7452E67-0B50-4473-8CEE-8F28F367AD96Q39402166-352F71B3-EA41-4FE1-A2D7-36F8DEBD97CEQ39586226-DA1E1A42-57B0-4EBE-8913-922801800AF2Q39748355-B2164BF1-41CD-4265-8BFB-770F707CA529Q40225890-4858C565-0F1F-4524-AEE2-5298BEC18FF9Q41873565-C0EBAD84-8AA6-4AC1-B413-3A9191B9BAECQ43036220-60F9ABD7-D944-49DD-8FDB-F6A7DF059F2FQ43109156-24C9AADA-AF5E-4CE9-9A01-EF9938716224Q43233892-6A211550-2F47-4281-836C-649379D22BE0Q43585852-7E442509-E449-46A2-A889-5EFEF8B3A2C0Q44846589-1B071B5F-862B-49EF-93B4-EC39A81A9E26Q45364959-970B3A74-447F-449C-A2E4-807A0B5B35D1Q45609955-5798CB63-8D91-4AC4-BDBB-C5EE25A9A37BQ52007964-73F10496-7F5F-4243-B25B-6B13B753E1C0Q53509316-0EE1AAC4-2138-4127-807A-9BB90B96D0CFQ53785723-9D8D1881-6250-438D-B976-EE41F322DAEF
P2860
Immunology of the healthy liver: old questions and new insights.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Immunology of the healthy liver: old questions and new insights.
@ast
Immunology of the healthy liver: old questions and new insights.
@en
Immunology of the healthy liver: old questions and new insights.
@nl
type
label
Immunology of the healthy liver: old questions and new insights.
@ast
Immunology of the healthy liver: old questions and new insights.
@en
Immunology of the healthy liver: old questions and new insights.
@nl
prefLabel
Immunology of the healthy liver: old questions and new insights.
@ast
Immunology of the healthy liver: old questions and new insights.
@en
Immunology of the healthy liver: old questions and new insights.
@nl
P2093
P356
P1433
P1476
Immunology of the healthy liver: old questions and new insights.
@en
P2093
P304
P356
10.1053/GAST.2001.20947
P407
P577
2001-01-01T00:00:00Z